High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 3, 2010, Pages

  Tao, Rong ^a,d   Hoover, Holly E ^a   Honbo, Norman ^a   Kalinowski, Mikaila ^a   Alano, Conrad C ^b,c   Karliner, Joel S ^a   Raffai, Robert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; CAY 10444; GLYCOGEN SYNTHASE KINASE 3BETA; HIGH DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PERTUSSIS TOXIN; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE DERIVATIVE; TRYPAN BLUE; UNCLASSIFIED DRUG; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FATE; CELL HYPOXIA; CELL THERAPY; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REOXYGENATION; SURVIVAL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MALE; MAP KINASE KINASE 1; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 77749273758     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00902.2009     Document Type: Article

References (45)

1. Argraves KM, Argraves WS. HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 48: 2325-2333, 2007.
2. Assmann G, Gotto AM Jr. HDL cholesterol and protective factors in atherosclerosis. Circulation 109, 23 Suppl 1: III8 -III14, 2004.
3. Bellosta S, Gomaraschi M, Canavesi M, Rossoni G, Monetti M, Franceschini G, Calabresi L. Inhibition of MMP-2 activation and release as a novel mechanism for HDL induced cardioprotection. FEBS Lett 580: 5974-5978, 2006.
4. Brinkmann V. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. Pharmacol Ther 115: 84-105, 2007.
5. Calabresi L, Rossoni G, Gomaraschi M, Sisto F, Berti F, Franceschini G. High density lipoproteins protect isolated rat hearts from ischemiareperfusion injury by reducing cardiac tumor necrosis factor-content and enhancing prostaglandin release. Circ Res 92: 330-337, 2003.
6. Chiesa G, Parolini C, Sirtori CR. Acute effects of high-density lipoproteins: biochemical basis and clinical findings. Curr Opinion Cardiol 23: 379-385, 2008.
7. Davis MD, Clemens JJ, Macdonald TL, Lynch KR. Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem 280: 9833-9841, 2005.
8. Di Napoli P, Di Muzio M, Contegiacomo G, Tiloca P, Spoletini L, Di Crecchio A, Gallina S, Barsotti A. Ischemic preconditioning of the myocardium: the role of changes in the permeability of the coronary microcirculation. Cardiologica 42: 59-67, 1997.
9. Gomaraschi M, Calabresi L, Rossoni G, Lametti S, Franceschini G, Stonik JA, Remaley AT. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-1 mimetic peptides. J Pharmacol Exp Ther 324: 776-783, 2008.
10. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353, 1955.
11. 1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. Br J Pharmacol 150: 470-479, 2007.
12. Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem 73: 321-354, 2004.
13. ε knockout mouse hearts. Am J Physiol Heart Circ Physiol 282: H1970-H1977, 2002.
14. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ. Glycogen synthase kinase-3 mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113: 1535-1549, 2004.
15. Karliner JS, Honbo N, Summers K, Gray MO, Goetzl EJ. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 33: 1713-1717, 2001.
16. Kimura T, Sato K, Kuwabara A, Tomura H, Ishiwara M, Kobayashi I, Ui M, Okajima F. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem 276: 31780-31785, 2001.
17. Kimura T, Sato K, Malchinkhuu E, Tomura H, Tamama K, Kuwabara A, Murakami M, Okajima F. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler Thromb Vasc Biol 23: 1283-1288, 2003.
18. Kimura T, Tomura H, Mogi C, Kuwabara A, Admiring A, Ishizuka T, Sekiguchi A, Ishiwara M, Im DS, Sato K, Murakami M, Okajima F. Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high-density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J Biol Chem 281: 37457-37467, 2006.
19. Koide Y, Hasegawa T, Takahashi A, Endo A, Mochizuki N, Nakagawa M, Nishida A. Development of novel EDG3 antagonists using a 3D database search and their structure-activity relationships. J Med Chem 45: 4629-4638, 2002.
20. Levkau B, Hermann S, Theilmeier G, van der Diet M, Chun J, Schober O, Schafers M. High-density lipoprotein stimulates myocardial perfusion in vivo. Circulation 110: 3355-3359, 2004.
21. Maceyka M, Payne SG, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, apoptosis. Biochim Biophys Acta 1585: 193-201, 2002.
22. Malchinkhuu E, Sato K, Muraki T, Ishikawa K, Kuwabara A, Okajima F. Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function. Biochem J 370: 817-827, 2003.
23. 3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 292: H2944-H2951, 2007.
24. i-mediated cAMP and contractile responses. J Biol Chem 283: 11954-11963, 2008.
25. Mochizuki S, Okumura M, Tanaka F, Sato T, Kagami A, Tada N, Nagano M. Ischemia-reperfusion arrhythmias and lipids: effect of human high and low-density lipoproteins on reperfusion arrhythmias. Cardiovasc Drug Ther 5, Suppl 2: 269-276, 1991.
26. Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, UIM, Okajima F. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352: 809-815, 2000.
27. Nofer JR, Levkau B, Wolinska I, Junker R, Fobker M, von Eckardstein A, Seedorf U, Assmann G. Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids. J Biol Chem 276: 34480-34485, 2001.
28. 3. J Clin Invest 113: 569-581, 2004.
29. Rader DJ. Regulation of reverse cholesterol transport and clinical implications. Am J Cardiol 92: 42J-49J, 2003.
30. Robbesyn F, Garcia V, Auge N, Vieira O, Frisach MF, Salvayre R, Negre-Salvayre A. HDL counterbalances the proinflammatory effect of oxidized LDL by inhibiting intracellular reactive oxygen species rise, proteasome activation, and subsequent NF-kappaB activation in smooth muscle cells. FASEB J 17: 743-745, 2003.
31. Rossoni G, Gomaraschi M, Verti F, Sirtori CR, Franceschini G, Calabresi L. Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury. J Pharmacol Exp Ther 308: 79-84, 2004.
32. Saba JD, Hla T. Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res 94: 724-734, 2004.
33. Saeed M, van Dijke CF, Mann JS, Wendland MF, Rosenau W, Higgins CB, Brasch RC. Histologic confirmation of microvascular hyperpermeability to macromolecular MR contrast medium in reperfused myocardial infarction. J Magn Reson Imaging 8: 561-567, 1998.
34. Sato K, Malchinkhuu E, Horiuchi Y, Mogi C, Tomura H, Tosaka M, Yoshimoto Y, Kuwabara A, Okajima F. HDL-like lipoproteins in cerebrospinal fluid affect neural cell activity through lipoprotein-associated sphingosine 1-phosphate. Biochem Biophys Res Commun 359: 649-654, 2007.
35. Skepper JN, Pierson RN, Young VK, Rees JA, Powell JM, Navaratnam V, Cary NR, Tew DN, Bacon PJ, Wallwork J, White DJ, Menon DK. Cytochemical demonstration of sites of hydrogen peroxide generation and increased vascular permeability in isolated pig hearts after ischaemia and reperfusion. Microsc Res Tech 42: 369-385, 1998.
36. Sattler K, Levkau B. Sphingosine-1-phosphate as a mediator of highdensity lipoprotein effects in cardiovascular protection. Cardiovasc Res 82: 201-211, 2009.
37. Tamama K, Tomura H, Sato K, Malchinkhuu E, Damirin A, Kimura T, Kuwabara A, Murakami M, Okajima F. High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis 178: 19-23, 2005.
38. Tao R, Zhang J, Vessey DA, Honbo N, Karliner JS. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes. Cardiovasc Res 74: 56-63, 2007.
39. 1 receptor-mediated extracellular signal-related kinase signaling and desensitization. J Cardiovasc Pharmacol 53: 486-494, 2009.
40. 3 lysophospholipid receptor. Circulation 114: 1403-1409, 2006.
41. Tilton RG, Daugherty A, Sutera SP, Larson KB, Land MP, Rateri DL, Kilo C, Williamson JR. Myocyte contracture, vascular resistance, and vascular permeability after global ischemia in isolated hearts from alloxaninduced diabetic rabbits. Diabetes 38: 1484-1491, 1989.
42. 1-selective agonist SEW2871 exacerbates reperfusion arrhythmias. J Cardiovasc Pharmacol 50: 660-669, 2007.
43. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y, Kume S. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo) 121: 969-973, 1997.
44. Zhang J, Honbo N, Goetzl EJ, Chatterjee K, Karliner JS, Gray MO. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol 293: H3150-H3158, 2007.
45. Zhou YY, Wang SQ, Zhu WZ, Chruscinski A, Kobilka BK, Ziman B, Wang S, Lakatta EG, Cheng H, Xiao RP. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. Am J Physiol Heart Circ Physiol 279: H429-H436, 2000.